false 0001584831 0001584831 2024-08-08 2024-08-08 0001584831 OXBR:OrdinarySharesParValue0.001Member 2024-08-08 2024-08-08 0001584831 OXBR:WarrantsToPurchaseOrdinarySharesMember 2024-08-08 2024-08-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 8, 2024

 

 

 

OXBRIDGE RE HOLDINGS LIMITED

(Exact Name of Registrant as Specified in Charter)

 

Cayman Islands   001-36346   98-1150254
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

Suite 201,
42 Edward Street, George Town
P.O. Box 469
Grand Cayman, Cayman Islands
  KY1-9006
(Address of Principal Executive Office)   (Zip Code)

 

Registrant’s telephone number, including area code: (345) 749-7570

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading symbol   Name of each exchange on which registered
Ordinary Shares (par value $0.001)   OXBR   The Nasdaq Stock Market LLC
Warrants to Purchase Ordinary Shares   OXBRW  

The Nasdaq Stock Market LLC

(The Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 2.02 Results of Operations and Financial Condition

 

On August 8, 2024, Oxbridge Re Holdings Limited issued a press release announcing its financial results for the quarter and six months ended June 30, 2024. A copy of the press release is attached hereto as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.

 

The information in this item shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of Section 18, nor shall it be deemed incorporated by reference in any of the Company’s filings under the Securities Act of 1933, as amended or the Exchange Act, except to the extent, if any, expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

See the Exhibit Index set forth below for a list of exhibits included with this Form 8-K.

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  OXBRIDGE RE HOLDINGS LIMITED
   
  /s/ Wrendon Timothy
Date: August 8, 2024 Wrendon Timothy
  Chief Financial Officer and Secretary
  (Principal Accounting Officer and
  Principal Financial Officer)

 

A signed original of this Form 8-K has been provided to Oxbridge Re Holdings Limited and will be retained by Oxbridge Re Holdings Limited and furnished to the Securities and Exchange Commission or its staff upon request.

 

 
 

 

EXHIBIT INDEX

 

Exhibit No.   Description
     
99.1   Press Release, dated August 8, 2024
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

Exhibit 99.1

 

 

Company Contact:

Oxbridge Re Holdings Limited

Jay Madhu, CEO

345-749-7570

jmadhu@oxbridgere.com

 

Oxbridge Re Reports Update on Business and Second Quarter 2024 Results

 

GRAND CAYMAN, Cayman Islands (August 8, 2024) — Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), together with its subsidiaries which is engaged in the business of tokenized Real-World Assets (“RWAs”) initially in the form of tokenized reinsurance securities, and reinsurance solutions to property and casualty insurers in the Gulf Coast region of the United States, reported its results for the three and six months ended June 30, 2024.

 

“Our stable performance persisted into the second quarter of 2024, with no losses incurred,” stated Jay Madhu, Chairman and Chief Executive Officer of Oxbridge Re Holdings.

 

“Following Delta CatRe’s targeted 42% payout last year, which was successfully exceeded at 49%, we are pleased to announce the completion of EpsilonCat Re private placement of approximately $2.8 million in tokenized securities within our RWA/Web3-focused subsidiary, SurancePlus Inc. This alternative investment leverages key aspects of blockchain technology to create a well-designed digital security, issued on the Avalanche blockchain,” Mr. Madhu continued. “Provided there are no losses from our reinsurance contracts, investors in EpsilonCat Re tokenized securities can expect an estimated annual return of 42%.

 

We also recently announced a strategic partnership with Zoniqx, which has issued over $4 billion in assets on-chain to date. SurancePlus is now a well-capitalized business with substantial growth potential for our shareholders. We are proud of this accomplishment and look forward to this exciting new entity diversifying and accelerating our growth in the RWA space in the coming years.”

 

“Looking ahead, with a strong balance sheet, no debt, and a well-diversified business from our recent transactions, we remain highly confident in our future ability to deliver shareholder value,” concluded Jay Madhu.

 

Financial Performance

 

For the three months ended June 30, 2024, the Company generated a net loss of $821,000 or $(0.14) per basic and diluted common share compared to net loss of $85,000 or ($0.01) per basic and diluted common share in the second quarter of 2023. The decrease is due primarily negative change in the fair value of equity securities and other investments during the quarter. For the six months ended June 30, 2024, the Company generated a net loss of $1.73 million or ($0.29) per basic and diluted common share compared to a net profit of $57,000 or $0.01 basic and diluted common share for the six months ended June 30, 2023. The worsened results were primarily due to lower total revenues driven by the increase in unrealized losses on other investment and equity securities.

 

Net premiums earned for the three months ended June 30, 2024 were $564,000 compared to $183,000 in the same prior year period. For the six months ended June 30, 2024 net premiums earned were $1.1 million compared to $183,000 in the prior year. The increases are primarily due to the prior periods recognizing only one month of premiums because of premium acceleration on the reinsurance contracts in force. In contrast, the quarter and six months ended June 30, 2024, recognized a full three and six months of premiums, respectively.

 

 
 

 

There were no losses incurred for the three and six months ended June 30, 2024 or 2023.

 

Total expenses were $628,000 for the three months ended June 30, 2024 compared to $697,000 for the same period in the prior year. For the six months ended June 30, 2024 total expenses were $1.17 million compared to $1.1 million in the prior year. The increase was due to higher policy and acquisition costs when compared to the prior year.

 

At June 30, 2024, cash and cash equivalents, and restricted cash and cash equivalents were $3.98 million compared to $3.7 million at December 31, 2023.

 

Financial Ratios

 

Loss Ratio. The loss ratio, which measures underwriting profitability, is the ratio of losses and loss adjustment expenses incurred to net premiums earned. The loss ratio was 0% for the period ended June 30, 2024 and 2023 due to no loss or loss adjustment expenses in either period.

 

Acquisition Cost Ratio. The acquisition cost ratio, which measures operational efficiency and compares policy acquisition costs with net premiums earned, increased marginally to 11.0% for the three and six-month periods ended June 30, 2024 from 10.9% for the same period last year.

 

Expense Ratio. The expense ratio, which measures operating performance, compares policy acquisition costs and general and administrative expenses with net premiums earned. The expense ratio decreased to 105.7% for the six months ended June 30, 2024 from 601.6% in the prior year due to the higher levels of premium earned during the period.

 

Combined ratio. The combined ratio, which is used to measure underwriting performance, is the sum of the loss ratio and the expense ratio. The combined ratio decreased to 105.7% for the six months ended June 30, 2023 from 601.6% due to the higher levels of premium earned during the period.

 

SurancePlus Offering

 

On July 11, 2024, SurancePlus Inc. (“SurancePlus”), an indirect wholly owned subsidiary of Oxbridge Re Holdings Limited (“Oxbridge”), completed its private placement (the “Private Placement”) of Participation Shares (the “Securities”) represented by digital tokens issued under a 3-year Participation Share Investment Contract (the “PSIC”). On July 11, 2024, SurancePlus entered into subscription agreements with accredited investors and non-U.S. persons in the Private Placement with respect to 287,705 of the Participation Shares represented by the digital tokens, EpsilonCat Re at a purchase price of $10.00 per Participation Share for aggregate gross proceeds of $2,878,048. The Participation Shares are not shares in SurancePlus and shall have no preemptive right or conversion rights. The Participation Shares solely confer contractual rights against SurancePlus as contained in the PSIC. The aggregate amount raised in the Private Placement was $2,878,048 for the issuance of 287,804 Participation Shares represented by Digital Tokens of which approximately $1,469,000 was received from third-party investors and approximately $1,409,000 from Oxbridge Re Holdings Limited. Approximately $312,000 and $299,000 of management fees were deducted from the gross proceeds from the third-party investors and Oxbridge Re Holdings Limited, respectively. The tokens were issued on the Avalanche blockchain. Ownership of DeltaCat Re tokenized reinsurance securities indirectly confers fractionalized interests in reinsurance contracts underwritten by Oxbridge Re’s reinsurance subsidiary, Oxbridge Re NS, for the 2024-2025 treaty year.

 

 
 

 

Conference Call

 

Management will host a conference call later today to discuss these financial results, followed by a question and-answer session. President and Chief Executive Officer Jay Madhu and Chief Financial Officer Wrendon Timothy will host the call starting at 4:30 p.m. Eastern time. The live presentation can be accessed by dialing the number below or by clicking the webcast link available on the Investor Information section of the company’s website at www.oxbridgere.com.

 

Date: August 8, 2024

Time: 4.30 p.m. Eastern time

Toll-free number: 877 524-8416

International number: +1 412 902-1028

Passcode (required): 13746518

 

Please call the conference telephone number 10 minutes before the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact InComm Conferencing at 201 493-6280 or 877 804-2066

 

A replay of the call will be available by telephone after 4:30 p.m. Eastern time on the same day of the call and via the Investor Information section of Oxbridge’s website at www.oxbridgere.com until August 22nd, 2024.

 

Toll-free replay number: 877-660-6853

International replay number: +1-201-612-7415

Conference ID: 13746518

 

About Oxbridge Re Holdings Limited

 

 

Oxbridge Re Holdings Limited (NASDAQ: OXBR, OXBRW) (“Oxbridge Re”) is headquartered in the Cayman Islands. The company offers tokenized Real-World Assets (“RWAs”) as tokenized reinsurance securities and reinsurance business solutions to property and casualty insurers, through its wholly owned subsidiaries SurancePlus Inc, Oxbridge Re NS, and Oxbridge Reinsurance Limited.

 

Insurance businesses in the Gulf Coast region of the United States purchase property and casualty reinsurance through our licensed reinsurers Oxbridge Reinsurance Limited and Oxbridge Re NS.

 

Our new Web3-focused subsidiary, SurancePlus Inc. (“SurancePlus”), has developed the first “on-chain” reinsurance RWA of its kind to be sponsored by a subsidiary of a publicly traded company. By digitizing interests in reinsurance contracts as on-chain RWAs, SurancePlus has democratized the availability of reinsurance as an alternative investment to both U.S. and non-U.S. investors.

 

Forward-Looking Statements

 

This press release may contain forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project” and other similar words and expressions are intended to signify forward-looking statements. Forward-looking statements are not guarantees of future results and conditions but rather are subject to various risks and uncertainties. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section entitled “Risk Factors” contained in our Form 10-K filed with the Securities and Exchange Commission (“SEC”) on 26th March 2024. The occurrence of any of these risks and uncertainties could have a material adverse effect on the Company’s business, financial condition and results of operations. Any forward-looking statements made in this press release speak only as of the date of this press release and, except as required by law, the Company undertakes no obligation to update any forward-looking statement contained in this press release, even if the Company’s expectations or any related events, conditions or circumstances change.

 

 
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Balance Sheets

(expressed in thousands of U.S. Dollars, except per share and share amounts)

 

  

At

June 30, 2024

  

At

December 31, 2023

 
   (Unaudited)     
Assets          
Investments:          
Equity securities, at fair value (cost: $1,563 and $1,926)  $213    680 
Cash and cash equivalents   3,594    495 
Restricted cash and cash equivalents   391    3,250 
Premiums receivable   2,118    977 
Other Investments   965    2,478 
Loan Receivable   -    100 
Due from Related Party   63    63 
Deferred policy acquisition costs   240    101 
Operating lease right-of-use assets   124    9 
Prepayment and other assets   113    96 
Property and equipment, net   2    4 
Total assets  $7,823    8,253 
           
Liabilities and Shareholders’ Equity          
           
Notes payable to noteholders   118    118 
Notes payable to Epsilon DeltaCat Re Tokenholders   1,239    1,523 
Unearned Premium Reserve   2,181    915 
Operating lease liabilities   124    9 
Accounts payable and other liabilities   374    356 
Total liabilities   4,036    2,921 
           
Shareholders’ equity:          
Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 6,036,579 and 5,870,234 shares issued and outstanding)   6    6 
Additional paid-in capital   32,921    32,740 
Accumulated Deficit   (29,140)   (27,414)
Total shareholders’ equity   3,787    5,332 
Total liabilities and shareholders’ equity  $7,823    8,253 

 

 
 

 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES

Consolidated Statements of Operations

(Unaudited)

(expressed in thousands of U.S. Dollars, except per share amounts)

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2024   2023   2024   2023 
                 
Revenue                    
Assumed premiums  $2,379    2,196    2,379    2,196 
Change in unearned premiums reserve   (1,815)   (2,013)   (1,266)   (2,013)
                     
Net premiums earned   564    183    1,113    183 
SurancePlus management fee income   312    300    312    300 
Net investment and other income   65    79    126    168 
Interest and gain on redemption of loan receivable   -    -    41    - 
Unrealized (loss) gain on other investments   (825)   124    (1,513)   505 
Change in fair value of equity securities   (72)   5    (160)   81 
                     
Total revenue   44    691    (81)   1,237 
                     
Expenses                    
Policy acquisition costs and underwriting expenses   62    20    122    20 
General and administrative expenses   566    677    1,054    1,081 
                     
Total expenses   628    697    1,176    1,101 
                     
Income (Loss) before income attributable to noteholders and tokenholders   (584)   (6)   (1,257)   136 
                     
Income attributable to noteholders and tokenholders   (237)   (79)   (469)   (79)
                     
Net (loss) income  $(821)   (85)   (1,726)   57 
                     
(Loss) earnings per share                    
Basic and Diluted  $(0.14)   (0.01)   (0.29)   0.01 
                     
Weighted-average shares outstanding                    
Basic and Diluted   6,010,561    5,870,234    6,007,868    5,863,973 
                     
Performance ratios to net premiums earned:                    
Loss ratio   0.0%   0.0%   0.0%   0.0%
Acquisition cost ratio   11.0%   10.9%   11.0%   10.9%
Expense ratio   111.3%   380.9%   105.7%   601.6%
Combined ratio   111.3%   380.9%   105.7%   601.6%

 

 

 

v3.24.2.u1
Cover
Aug. 08, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 08, 2024
Entity File Number 001-36346
Entity Registrant Name OXBRIDGE RE HOLDINGS LIMITED
Entity Central Index Key 0001584831
Entity Tax Identification Number 98-1150254
Entity Incorporation, State or Country Code E9
Entity Address, Address Line One Suite 201
Entity Address, Address Line Two 42 Edward Street, George Town
Entity Address, Address Line Three P.O. Box 469
Entity Address, City or Town Grand Cayman
Entity Address, Country KY
Entity Address, Postal Zip Code KY1-9006
City Area Code (345)
Local Phone Number 749-7570
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Ordinary Shares (par value $0.001)  
Title of 12(b) Security Ordinary Shares (par value $0.001)
Trading Symbol OXBR
Security Exchange Name NASDAQ
Warrants to Purchase Ordinary Shares  
Title of 12(b) Security Warrants to Purchase Ordinary Shares
Trading Symbol OXBRW
Security Exchange Name NASDAQ

Oxbridge Re (NASDAQ:OXBRW)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Oxbridge Re Charts.
Oxbridge Re (NASDAQ:OXBRW)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Oxbridge Re Charts.